Fundamental Analysis
70 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +503.1% | +150.6% | 2 / 3 | -23.4% | +3.02 pp | +19.36 pp | -5.7% | 0.07 | — | 118 | −23,4% | 18,9 | +458,6% | — | 8.12 | — |
| Pts | 12 | 12 | 8 | 0 | 12 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 7.200 (close price on 2026-10-19)EPS (TTM): −623,0
Financial charts
1.Revenue & growth
VND bn118Q2/26
1.Revenue & growth
VND bn118Q2/26
2.Profit & growth
VND bn19,1Q2/26
3.Profit mix (Penman)
VND bn-70,9Q2/26
4.Margins & cost structure
%10.8%Q2/26
5.Returns & cash cycle
% · days-0.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn1.353Q2/26
8.Funding & debt health
VND bn · times1.353Q2/26
9.Revenue backlog
VND bn0,02Q2/26
10.Valuation
times · %-12,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %172Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-199%
averaged over 1 quarter(s)
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26